Literature DB >> 23462766

FDA warning: New batch of fake bevacizumab found.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23462766     DOI： 10.1001/jama.2013.1719

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  After counterfeit Avastin®--what have we learned and what can be done?

Authors:  Tim K Mackey; Raphael Cuomo; Camille Guerra; Bryan A Liang
Journal:  Nat Rev Clin Oncol       Date:  2015-03-03       Impact factor: 66.675

2.  An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.

Authors:  Raphael E Cuomo; Tim K Mackey
Journal:  BMJ Open       Date:  2014-12-02       Impact factor: 2.692

3.  Substandard and falsified medical products: bibliometric analysis and mapping of scientific research.

Authors:  Waleed M Sweileh
Journal:  Global Health       Date:  2021-09-23       Impact factor: 4.185

4.  Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study.

Authors:  Kevin Pozsgai; Gergő Szűcs; Anikó Kőnig-Péter; Orsolya Balázs; Péter Vajda; Lajos Botz; Róbert György Vida
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.